A First Suspected Case of Fibrosing Mediastinitis After Anti–PD-1 Therapy

We describe a first suspected case of fibrosing mediastinitis following anti–programmed death (PD)-1 therapy, pembrolizumab. Multimodality imaging, including cardiac magnetic resonance imaging, and a multidisciplinary team approach were integral to the diagnosis. If further substantiated, systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Carolyn J., Vasu, Sujethra, Urbain, Jean L., Triozzi, Pierre L., Pokharel, Yashashwi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Imaging Vignette
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588595/
https://www.ncbi.nlm.nih.gov/pubmed/36299648
http://dx.doi.org/10.1016/j.jaccas.2022.09.002
_version_ 1784814145663664128
author Park, Carolyn J.
Vasu, Sujethra
Urbain, Jean L.
Triozzi, Pierre L.
Pokharel, Yashashwi
author_facet Park, Carolyn J.
Vasu, Sujethra
Urbain, Jean L.
Triozzi, Pierre L.
Pokharel, Yashashwi
author_sort Park, Carolyn J.
collection PubMed
description We describe a first suspected case of fibrosing mediastinitis following anti–programmed death (PD)-1 therapy, pembrolizumab. Multimodality imaging, including cardiac magnetic resonance imaging, and a multidisciplinary team approach were integral to the diagnosis. If further substantiated, systematic surveillance after anti–PD-1 therapy for fibrosing mediastinitis may be warranted. (Level of Difficulty: Intermediate.)
format Online
Article
Text
id pubmed-9588595
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95885952022-10-25 A First Suspected Case of Fibrosing Mediastinitis After Anti–PD-1 Therapy Park, Carolyn J. Vasu, Sujethra Urbain, Jean L. Triozzi, Pierre L. Pokharel, Yashashwi JACC Case Rep Imaging Vignette We describe a first suspected case of fibrosing mediastinitis following anti–programmed death (PD)-1 therapy, pembrolizumab. Multimodality imaging, including cardiac magnetic resonance imaging, and a multidisciplinary team approach were integral to the diagnosis. If further substantiated, systematic surveillance after anti–PD-1 therapy for fibrosing mediastinitis may be warranted. (Level of Difficulty: Intermediate.) Elsevier 2022-10-19 /pmc/articles/PMC9588595/ /pubmed/36299648 http://dx.doi.org/10.1016/j.jaccas.2022.09.002 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Imaging Vignette
Park, Carolyn J.
Vasu, Sujethra
Urbain, Jean L.
Triozzi, Pierre L.
Pokharel, Yashashwi
A First Suspected Case of Fibrosing Mediastinitis After Anti–PD-1 Therapy
title A First Suspected Case of Fibrosing Mediastinitis After Anti–PD-1 Therapy
title_full A First Suspected Case of Fibrosing Mediastinitis After Anti–PD-1 Therapy
title_fullStr A First Suspected Case of Fibrosing Mediastinitis After Anti–PD-1 Therapy
title_full_unstemmed A First Suspected Case of Fibrosing Mediastinitis After Anti–PD-1 Therapy
title_short A First Suspected Case of Fibrosing Mediastinitis After Anti–PD-1 Therapy
title_sort first suspected case of fibrosing mediastinitis after anti–pd-1 therapy
topic Imaging Vignette
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588595/
https://www.ncbi.nlm.nih.gov/pubmed/36299648
http://dx.doi.org/10.1016/j.jaccas.2022.09.002
work_keys_str_mv AT parkcarolynj afirstsuspectedcaseoffibrosingmediastinitisafterantipd1therapy
AT vasusujethra afirstsuspectedcaseoffibrosingmediastinitisafterantipd1therapy
AT urbainjeanl afirstsuspectedcaseoffibrosingmediastinitisafterantipd1therapy
AT triozzipierrel afirstsuspectedcaseoffibrosingmediastinitisafterantipd1therapy
AT pokharelyashashwi afirstsuspectedcaseoffibrosingmediastinitisafterantipd1therapy
AT parkcarolynj firstsuspectedcaseoffibrosingmediastinitisafterantipd1therapy
AT vasusujethra firstsuspectedcaseoffibrosingmediastinitisafterantipd1therapy
AT urbainjeanl firstsuspectedcaseoffibrosingmediastinitisafterantipd1therapy
AT triozzipierrel firstsuspectedcaseoffibrosingmediastinitisafterantipd1therapy
AT pokharelyashashwi firstsuspectedcaseoffibrosingmediastinitisafterantipd1therapy

Ejemplares similares